<html>
<head>PUBMED IDs for PEO2</head>
<body bgcolor='#C5F0F2'><h1>PEO2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21571862/'>HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.</a> October 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22183581/'>The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer.</a> April 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/26021697/'>Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patients.</a> March 15  2015<br></body></html>
